Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Transplantation and Cellular Therapy|March 15, 2025
Defining the Quality Attributes for Tumor-Infiltrating Lymphocyte Medicinal ProductsJustin J Lievense, Cynthia Nijenhuis, Inge Jedema, et al.Investigational New Drugs|November 8, 2014
Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomasAnne-Charlotte Dubbelman, Hilde Rosing, Cynthia Nijenhuis, et al.Journal for Immunotherapy of Cancer|March 26, 2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trialRenske M T Ten Ham, Maartje W Rohaan, Inge Jedema, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced MelanomaJoachim S Granhøj, Sigrid M H Mannering, Kasper Madsen, et al.The New England Journal of Medicine|December 8, 2022
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced MelanomaMaartje W Rohaan, Troels H Borch, Joost H van den Berg, et al.Pageof 1